US FDA clears Great Basin whooping cough test
Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy
The U.S. FDA granted Great Basin Scientific Inc. clearance for its bordetella direct test following a 510(k) submission on Feb. 1.
Great Basin's sample-to-result test detects bordetella pertussis, also known as whooping cough, finding the bacterium behind the highly contagious respiratory disease.